ValiRx plc (LON:VAL – Get Free Report) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 0.44 and traded as low as GBX 0.31. ValiRx shares last traded at GBX 0.34, with a volume of 13,535,192 shares trading hands.
ValiRx Stock Performance
The company has a quick ratio of 1.27, a current ratio of 6.65 and a debt-to-equity ratio of 0.44. The firm has a 50-day moving average of GBX 0.36 and a 200 day moving average of GBX 0.44. The stock has a market capitalization of £2.48 million, a P/E ratio of -0.36 and a beta of 0.59.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Stories
- Five stocks we like better than ValiRx
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- This makes me furious
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
